Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Strata Skin Sciences ( (SSKN) ) has provided an announcement.
On December 10, 2025, Strata Skin Sciences held its annual meeting of stockholders, where several key decisions were made. The stockholders elected five director nominees to the board, approved an amendment to the 2016 Omnibus Incentive Plan to increase the number of shares by 520,000, and ratified the selection of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (SSKN) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Strata Skin Sciences stock, see the SSKN Stock Forecast page.
Spark’s Take on SSKN Stock
According to Spark, TipRanks’ AI Analyst, SSKN is a Neutral.
The overall stock score is primarily impacted by the company’s weak financial performance and bearish technical indicators. While there are some positive developments from the earnings call, such as market expansion and litigation success, these are overshadowed by significant revenue declines and ongoing financial challenges.
To see Spark’s full report on SSKN stock, click here.
More about Strata Skin Sciences
Average Trading Volume: 4,103,649
Technical Sentiment Signal: Sell
Current Market Cap: $8.13M
See more insights into SSKN stock on TipRanks’ Stock Analysis page.